MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$645K
(49.81%↑ Y/Y)
Foreign currency
translation adjustments
$174K
(148.74%↑ Y/Y)
Net loss
-$819K
(11.75%↑ Y/Y)
Income tax benefit
(expense)
-$130K
(-1544.44%↓ Y/Y)
Net loss before
income taxes
-$949K
(-3.26%↓ Y/Y)
Revenues
$4,349K
(22.03%↑ Y/Y)
Loss from operations
-$678K
(34.24%↑ Y/Y)
Other (expense)
income, net
-$271K
(-341.96%↓ Y/Y)
Gross profit
$1,650K
(29.92%↑ Y/Y)
Cost of revenues
$2,699K
(17.65%↑ Y/Y)
Total operating
expenses
$2,328K
(1.17%↑ Y/Y)
Selling, general and
administrative
$1,771K
(-5.50%↓ Y/Y)
Research and development
$557K
(30.44%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)